SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflixs upcoming Q3 earnings report is the main focus, with traders watching guidance, subscriber engagement and advertising growth after a steep share-price decline and recent layoffs and content-leadership changes. Views are split between hopes for a rebound if results or outlook exceed subdued expectations and bets on further losses if growth concerns persist.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Modernas rally is tied to enthusiasm for its Merck-partnered personalized melanoma vaccine after positive Phase 3 topline results, with traders focused on the detailed data presentation at ESMO. Bulls see validation of a broader cancer-vaccine platform and momentum, while bears argue expectations and valuation are stretched and warn of a possible sell-the-news reaction.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Traders are citing a reported ClinicalTrials.gov update adding a site to Sareptas ENHANCE Elevidys safety study as a possible trigger for the rebound, though they note the study timeline reportedly slipped. The broader debate centers on whether upcoming DM1 and FSHD data can support a recovery, with some traders pointing to short covering and others stressing that those clinical results remain unproven.

Sea Ltd. is an internet and mobile platform company, which engages in the provision of online gaming services. It operates through the following segments: Digital Entertainment, E-Commerce, and Digital Financial Services. The Digital Entertainment segment offers and develops mobile and PC online games. The E-Commerce segment manages a third-party marketplace through the Shopee mobile app and websites that connect buyers and sellers. The Digital Financial Services segment includes a variety of payment services and loans to individuals and businesses through SeaMoney. Sea was founded by Xiao Dong Li, Gang Ye, and Jing Ye Chen on May 8, 2009 and is headquartered in Singapore.

Sea Ltd - ADR

Seas sharp selloff and fresh low are being linked by traders to plans for a potential Monee listing and the launch of Sea Cloud, alongside concerns about spending and competition in e-commerce. Some see a Monee separation as value-unlocking, while others view the plans and uncertainty around them as a reason to sell; claims of further undisclosed bad news remain speculation.

GE Aerospace is an American aircraft company, which engages in the provision of jet and turboprop engines, as well as integrated systems for commercial, military, business, and general aviation aircraft. The firm's portfolio of brands includes Avio Aero, Unison, GE Additive, and Dowty Propellers. It operates through the following segments: Commercial Engines and Services, Defense and Propulsion Technologies, and Corporate and Other. The Commercial Engines and Services segment is involved in the design, development, manufacturing, and servicing of jet engines for commercial airframes, as well as business aviation and aeroderivative applications. The Defense and Propulsion Technologies segment offers defense engines and critical aircraft systems. The Corporate and Other segment relates to corporate functions and operations costs. The company was founded by Thomas Alva Edison in 1878 and is headquartered in Evendale, OH.

GE Aerospace

GEs earnings beat and higher outlook have been met with a sharp selloff, prompting traders to question why strong demand and orders are not lifting the shares. The debate centers on rising costs, weaker cash conversion and an insurance loss, while some investors view the reaction as excessive given the improved guidance.

General Motors Co. engages in the designing, manufacturing, and selling of trucks, crossovers, cars, and automobile parts, and in providing software-enabled services and subscriptions. It operates through the following segments: GMNA, GMI, Cruise, and GM Financial. The company was founded by William C. Durant on September 16, 1908 and is headquartered in Detroit, MI.

General Motors Company

GM is drawing attention after its quarterly earnings beat and improved cash-flow outlook failed to prevent a sharp selloff, as traders focused on narrowed full-year profit guidance with no increase to its midpoint. Some see the new buyback and cash generation as support for the shares, while others argue the outlook disappointed despite the strong quarter.

Myriad Genetics, Inc. is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. It develops and commercializes molecular tests that help patients and providers uncover genetic insights. The company was founded by Walter A. Gilbert, Mark H. Skolnick, and Peter D. Meldrum in May 1991 and is headquartered in Salt Lake City, UT.

Myriad Genetics, Inc.

Myriads agreement to sell its prenatal testing business to Labcorp is driving the sharp rally, with traders viewing the cash proceeds as a potential balance-sheet and strategic reset. Others argue the divestiture removes a significant revenue stream and leaves concerns about debt and weakness in the remaining business; the transaction is still pending approval and closing.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

Attention centers on TG Therapeutics MSToronto presentations, especially initial Phase 1 azer-cel data in progressive MS and additional BRIUMVI results, with commercial growth and a future subcutaneous formulation also part of the bullish case. Traders are anticipating a catalyst-driven move, though some caution that the azer-cel results remain uncertain and complain that the shares have struggled to break out of a trading range.

The Compound Governance Token is a governance token on the Compound Finance lending protocol, COMP allows the owner to delegate voting rights to the address of their choice; the owner’s wallet, another user, an application, or a DeFi expert. Anybody can participate in Compound governance by receiving delegation, without needing to own COMP.  Anybody with 1% of COMP delegated to their address can propose a governance action; these are simple or complex sets of actions, such as adding support for a new asset, changing an asset’s collateral factor, changing a market’s interest rate model, or changing any other parameter or variable of the protocol that the current administrator can modify.

Compound

A sharp COMP rally has sparked breakout talk, with traders pointing to rising momentum, chart patterns, and the tokens limited supply; others remain skeptical, calling it a volatile bounce and questioning whether gains can hold.

Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA.

Rapport Therapeutics Inc.

Rapport Therapeutics Inc

RAP-219s Phase 2 trial in bipolar mania met its primary and secondary endpoints, prompting bullish trading and analyst optimism, including an upgrade. The community is divided over the modest placebo-adjusted benefit and concerns about agitation and discontinuations; the initial surge faded as traders debated whether the data justify further upside.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

BNY Announces Pricing of Public Offering of $1,250,000,000 of Depositary Shares Representing Interests in Preferred Stock

BNY Announces Pricing of Public Offering of $1,250,000,000 of Depositary Shares Representing Interests in Preferred Stock BNY Announces Pricing of Public Offering of $1,250,000,000 of Depositary Shares Representing Interests in Preferred StockPR NewswireNEW YORK, Oct. 19, 2026 NEW YORK, Oct. 19...

China's Treasury Pile Is Shrinking on Paper. The Custody Data Tell a Different Story

China's Treasury Pile Is Shrinking on Paper. The Custody Data Tell a Different Story China's Treasury Pile Is Shrinking on Paper. The Custody Data Tell a Different StoryPR NewswireNEW YORK, Oct. 19, 2026 NEW YORK, Oct. 19, 2026 /PRNewswire/ -- American News Group News Commentary- China held $590.7...

Bank of New York Mellon: 3 Key Takeaways for Long-Term Investors

Key PointsThe company raised its 2026 operating leverage target to 500 basis points...

BNY Q3 Earnings Call Highlights Raised Outlook and AI Push

BNY raises 2026 revenue growth and operating leverage outlook as solid Q3 momentum, AI adoption and expanding securities services backs its growth strategy.

Company News for Oct 16, 2026

Companies in The News Are: ERIC, MRSH, RKLB, BNY

BNY Q3 Earnings Beat Estimates on Fee Income & NII Growth

BNY's Q3'26 earnings beat estimates as higher fee revenues, NII growth and expanding asset balances boost the results despite rising expenses.

TGE Value Creative Solutions Celebrates Recent NYSE Listing: NYSE Content Update

TGE Value Creative Solutions Celebrates Recent NYSE Listing: NYSE Content Update TGE Value Creative Solutions Celebrates Recent NYSE Listing: NYSE Content UpdatePR NewswireNEW YORK, Oct. 15, 2026NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, Oct. 15, 2026...

Compared to Estimates, BNY (BNY) Q3 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for BNY (BNY) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

BNY (BNY) Q3 Earnings and Revenues Beat Estimates

BNY (BNY) delivered earnings and revenue surprises of +4.87% and +2.06%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

The Bank Of New York Mellon Corp. Reveals Advance In Q3 Bottom Line

(RTTNews) - The Bank of New York Mellon Corp. (BK) revealed a profit for its third quarter that Increases, from the same period last year...

BNY reported 3Q26 total revenue of $5.68B, up 12% year over year, diluted EPS of $2.34, up 24%, and pre-tax operating margin of 38.5%.

BNY's noninterest expense increased 8%, reflecting higher revenue-related expenses and investments; deposit margin compression partially offset net interest income growth, while cumulative net outflows and the stronger U.S. dollar partially offset AUM growth.

BNY's fee revenue increased with net new business, client activity and market values; AUC/A increased with net client inflows and new business, while client demand continued to grow and launched solutions are meeting emerging needs.

The Bank of New York Mellon Corporation provides a range of financial products and services in the United States and internationally. It operates through Securities Services, Market and Wealth Services, Investment and Wealth Management, and Other segments. The Securities Services segment offers custody, trust and depositary, accounting, exchange-traded funds, middle-office solutions, transfer agency, services for private equity and real estate funds, foreign exchange, securities lending, liquidity/lending services, and data analytics. This segment also provides trustee, paying agency, fiduciary, escrow and other financial, issuer, and support services for brokers and investors. The Market and Wealth Services segment offers clearing and custody, investment, wealth and retirement solutions, technology and enterprise data management, trading, and prime brokerage services. This segment also provides integrated cash management solutions, including payments, foreign exchange, liquidity management, receivables processing, payables management, and trade finance, as well as U.S. government and global clearing, and tri-party services. The Investment and Wealth Management segment offers investment management strategies, investment products distribution, investment management, custody, wealth and estate planning, private banking, investment, and information management services. The Other segment provides corporate treasury, derivative and other trading, corporate and bank-owned life insurance, tax credit investment, other corporate investment, and business exit services. The company serves central banks and sovereigns, financial institutions, asset managers, insurance companies, corporations, local authorities and high net-worth individuals, and family offices. The Bank of New York Mellon Corporation was founded in 1784 and is headquartered in New York, New York.

Bank Of New York Mellon Corp

Top Wall Street Firms Compete To Manage Anthropic Staffers' Post IPO Fortunes

Equity

Bullish Sentiment

<ul class="summary-bullets"><li>Goldman Sachs, Bank of America, BNY Mellon, JPMorgan Chase, and Wells Fargo, alongside boutique advisories, are pitching to manage Anthropic employees' fortunes post-listing.&nbsp;</li><li>Anthropic requested detailed proposals from advisory firms regarding fee structures, service offerings, and operational capabilities to curate a recommended list of advisers for its staff.&nbsp;</li><li>The debut of the Claude developer is projected to mint numerous new millionaires, mirroring recent trends seen among employees preparing for major mega-IPOs.&nbsp;</li></ul>Major Wall Street institutions are aggressively pursuing wealth-management opportunities ahead of artificial intelligence developer Anthropic PBC’s anticipated initial public offering, Bloomberg reported.Financial heavyweights including Goldman Sachs Group Inc. (GS), Bank of America Corp. (BAC), JPMorgan Chase &amp; Co. (JPM), Wells Fargo &amp; Co. (WFC), and Bank of New York Mellon Corp.’s (BNY) wealth division are in active discussions with the startup, according to individuals familiar with the matter.&nbsp;Anthropic is seeking to curate a list of recommended financial advisers to help its staff manage upcoming financial payouts. Both Anthropic and representatives for the financial institutions declined to comment.<h2 class="st-heading-2">Formal Pitching Process Underway</h2>In recent weeks, the creator of the Claude AI assistant issued a formal request for information, inviting wealth managers and smaller boutique advisory firms to submit details regarding their fee structures, operational capacities, and service packages.The competitive push highlights the financial sector's eager appetite to capture new private wealth generated by the boom in artificial intelligence.Industry observers anticipate that the public listing could unlock extraordinary wealth for startup personnel who acquired equity relatively recently. Brandon Smith of advisory firm Laird Norton Wetherby noted that the rapid rise of the AI sector means equity granted even two years ago could yield substantial capital for staff."It is equivalent to a lottery ticket," Smith said, adding that it is highly reasonable to expect the listing to generate a wave of new millionaires.<h2 class="st-heading-2">Echoing Recent Tech Trends</h2>The surge in interest follows recent patterns seen among high-profile tech debuts, where employees have coordinated directly to secure specialized financial terms. Prior to SpaceX's listing, over 1,000 current and former staff members joined forces to negotiate discounted rates and specialized tax-planning services from wealth managers.As Anthropic prepares to list, Wall Street firms are working to position themselves to capture the incoming flood of private wealth.Retail sentiment on Stocktwits related to Anthropic was ‘bearish’ with ‘low’ message volumes.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.

The Anthropic logo is displayed on the screen of a smartphone with the company's branding in the background. (Photo by Samuel Boivin/NurPhoto via Getty Images)

Major financial institutions are competing to secure wealth-management mandates for Anthropic employees who stand to earn substantial payouts from the artificial intelligence startup's upcoming IPO.

Bank of America Corp

Goldman Sachs Group, Inc.

JPMorgan Chase & Co

Wells Fargo & Co.

Double beat (rev + EPS)

Revenue beat, EPS miss

EPS beat, revenue miss

Double miss

SpaceX ($SPCX) reports earnings after the close today. What do you expect?

Stocktwits

SpaceX

) reports earnings after the close today. What do you expect?

Current Price	$144.34
Prev Close	$142.44
Open	$143.11
Dividend Yield	1.72%
50-Day Moving Average	$154.22
Beta	0.84
Avg. Volume	3.82M
PE Ratio	15.74

52-Week High	$165.84
52-Week Low	$105.36
Market Capitalization	$96.65B
EPS (Annual)	$7.40
Price to Book	2.42
Revenue Per Employee	$843,035.34

Feed

News

Sentiment

Earnings

Fundamentals

Info

BNY Fundamentals